Shikiar Asset Management Inc. raised its stake in shares of Danaher Corporation (NYSE:DHR) by 1.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 57,272 shares of the conglomerate’s stock after purchasing an additional 710 shares during the period. Danaher Corporation accounts for about 2.1% of Shikiar Asset Management Inc.’s portfolio, making the stock its 19th biggest position. Shikiar Asset Management Inc.’s holdings in Danaher Corporation were worth $4,913,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently modified their holdings of the business. Fulton Bank N.A. purchased a new stake in Danaher Corporation during the third quarter valued at approximately $384,000. Neville Rodie & Shaw Inc. raised its position in Danaher Corporation by 6.0% during the third quarter. Neville Rodie & Shaw Inc. now owns 50,912 shares of the conglomerate’s stock valued at $4,367,000 after purchasing an additional 2,900 shares during the period. Curbstone Financial Management Corp raised its position in Danaher Corporation by 100.0% during the third quarter. Curbstone Financial Management Corp now owns 5,490 shares of the conglomerate’s stock valued at $471,000 after purchasing an additional 2,745 shares during the period. Park National Corp OH raised its position in Danaher Corporation by 18.9% during the third quarter. Park National Corp OH now owns 112,367 shares of the conglomerate’s stock valued at $9,639,000 after purchasing an additional 17,901 shares during the period. Finally, Bath Savings Trust Co raised its position in Danaher Corporation by 21.9% during the third quarter. Bath Savings Trust Co now owns 48,388 shares of the conglomerate’s stock valued at $4,151,000 after purchasing an additional 8,700 shares during the period. Institutional investors and hedge funds own 75.61% of the company’s stock.

In other Danaher Corporation news, CAO Robert S. Lutz sold 11,189 shares of the stock in a transaction on Monday, October 23rd. The stock was sold at an average price of $91.66, for a total transaction of $1,025,583.74. Following the sale, the chief accounting officer now owns 18,314 shares of the company’s stock, valued at approximately $1,678,661.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider William King sold 43,688 shares of the stock in a transaction on Thursday, August 31st. The shares were sold at an average price of $82.86, for a total value of $3,619,987.68. Following the sale, the insider now directly owns 45,748 shares in the company, valued at approximately $3,790,679.28. The disclosure for this sale can be found here. Insiders have sold a total of 279,628 shares of company stock worth $25,304,394 in the last ninety days. Insiders own 12.20% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Shikiar Asset Management Inc. Buys 710 Shares of Danaher Corporation (DHR)” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another site, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/11/08/shikiar-asset-management-inc-buys-710-shares-of-danaher-corporation-dhr.html.

Danaher Corporation (NYSE DHR) opened at $93.20 on Wednesday. Danaher Corporation has a 52 week low of $76.27 and a 52 week high of $93.16. The stock has a market capitalization of $64,426.95, a P/E ratio of 23.81, a P/E/G ratio of 2.20 and a beta of 1.02. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.42.

Danaher Corporation (NYSE:DHR) last announced its earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.05. The business had revenue of $4.53 billion for the quarter, compared to analysts’ expectations of $4.47 billion. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.87 EPS. analysts expect that Danaher Corporation will post 3.99 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were given a dividend of $0.14 per share. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.56 annualized dividend and a yield of 0.60%. Danaher Corporation’s dividend payout ratio (DPR) is presently 16.52%.

A number of research analysts have recently commented on DHR shares. Goldman Sachs Group, Inc. (The) reaffirmed a “neutral” rating and set a $83.00 target price on shares of Danaher Corporation in a research note on Tuesday, September 26th. Wells Fargo & Company started coverage on Danaher Corporation in a research note on Thursday, July 13th. They set a “market perform” rating and a $90.00 target price on the stock. Jefferies Group LLC reaffirmed a “buy” rating and set a $95.00 target price on shares of Danaher Corporation in a research note on Friday, August 4th. BidaskClub cut Danaher Corporation from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 1st. Finally, Zacks Investment Research cut Danaher Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 27th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $93.31.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.